Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

56.30
Delayed Data
As of May 25
 +1.33 / +2.42%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.06%
Year-to-Date
Novo Nordisk IDegLira Recommended by FDA Advisory Committee
May 25 / Zacks.com - Paid Partner Content
Businesses That Win Trait No. 3: Long-Term Thinking
May 24 / MotleyFool.com - Paid Partner Content
Sanofi Diabetes Drugs Briefing Documents Raise Concerns
May 24 / Zacks.com - Paid Partner Content